|Bid||48.47 x 800|
|Ask||0.00 x 800|
|Day's Range||51.00 - 53.13|
|52 Week Range||34.40 - 88.78|
|Beta (5Y Monthly)||1.51|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 01, 2020 - Sep 08, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||63.08|
DRAPER, Utah, July 15, 2020 -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”) today announced the closing of the underwritten public offering of an.
DRAPER, Utah, July 13, 2020 -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the closing of the underwritten public offering of 4,600,000.
HealthEquity intends to use the net proceeds from the offering to free up additional capital for organic and inorganic growth by pre-paying $200 million under its term loan facility, with the remaining proceeds to be used for general corporate purposes, which may include additional pre-payments under its term loan facility and/or potential acquisitions. Wells Fargo Securities, LLC and J.P. Morgan Securities LLC are acting as lead book-running managers for the offering. Goldman Sachs & Co. LLC, and RBC Capital Markets LLC are acting as book-running managers for the offering.